Plascencia-Cruz M, Plascencia-Hernandez A, De Armas-Rodriguez Y, Cervantes-Guevara G, Cervantes-Cardona G, Ramirez-Ochoa S
Trop Med Infect Dis. 2023; 8(3).
PMID: 36977138
PMC: 10055963.
DOI: 10.3390/tropicalmed8030137.
Wang Y, Zhou X, Saimi M, Huang X, Sun T, Fan G
Front Public Health. 2021; 9:680108.
PMID: 34222179
PMC: 8244732.
DOI: 10.3389/fpubh.2021.680108.
Borie R, Caro V, Nunes H, Kambouchner M, Cazes A, Antoine M
Infect Agent Cancer. 2021; 16(1):10.
PMID: 33549143
PMC: 7868019.
DOI: 10.1186/s13027-021-00351-w.
Pereira-Diaz E, Moreno-Verdejo F, de la Horra C, Guerrero J, Calderon E, Medrano F
Front Public Health. 2019; 7:275.
PMID: 31637227
PMC: 6788256.
DOI: 10.3389/fpubh.2019.00275.
Canas-Arboleda A, Hernandez-Florez C, Garzon J, Marcela Parra-Giraldo C, Burbano J, Cita-Pardo J
Braz J Infect Dis. 2019; 23(5):352-357.
PMID: 31545952
PMC: 9427795.
DOI: 10.1016/j.bjid.2019.08.008.
Prevalence and genotyping of Pneumocystis jirovecii in renal transplant recipients-preliminary report.
Szydlowicz M, Jakuszko K, Szymczak A, Piesiak P, Kowal A, Kopacz Z
Parasitol Res. 2018; 118(1):181-189.
PMID: 30392033
PMC: 6329730.
DOI: 10.1007/s00436-018-6131-0.
Role of Pneumocystis jirovecii in patients with different pulmonary underlying condition using a nested-PCR.
Martinez Lamas L, Perez Rodriguez M, Alvarez Ramos I, Bouza Soage M, Figueroa Lamas M, Alvarez Fernandez M
Rev Esp Quimioter. 2018; 31(4):336-343.
PMID: 29956896
PMC: 6172691.
Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.
Friedrich R, Rappold E, Bogdan C, Held J
J Clin Microbiol. 2018; 56(9).
PMID: 29899003
PMC: 6113455.
DOI: 10.1128/JCM.00464-18.
In vitro and in vivo activity of iclaprim, a diaminopyrimidine compound and potential therapeutic alternative against Pneumocystis pneumonia.
Aliouat E, Dei-Cas E, Gantois N, Pottier M, Pincon C, Hawser S
Eur J Clin Microbiol Infect Dis. 2018; 37(3):409-415.
PMID: 29330709
DOI: 10.1007/s10096-018-3184-z.
colonization in Chronic Obstructive Pulmonary Disease (COPD).
Khodavaisy S, Mortaz E, Mohammadi F, Aliyali M, Fakhim H, Badali H
Curr Med Mycol. 2017; 1(1):42-48.
PMID: 28680980
PMC: 5490321.
DOI: 10.18869/acadpub.cmm.1.1.42.
A Novel CD4 T Cell-Dependent Murine Model of Pneumocystis-driven Asthma-like Pathology.
Eddens T, Campfield B, Serody K, Manni M, Horne W, Elsegeiny W
Am J Respir Crit Care Med. 2016; 194(7):807-820.
PMID: 27007260
PMC: 5074654.
DOI: 10.1164/rccm.201511-2205OC.
Evaluation of Loop-Mediated Isothermal Amplification Assay for the Detection of Pneumocystis jirovecii in Immunocompromised Patients.
Singh P, Singh S, Mirdha B, Guleria R, Agarwal S, Mohan A
Mol Biol Int. 2015; 2015:819091.
PMID: 26664746
PMC: 4668309.
DOI: 10.1155/2015/819091.
Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.
Mori S, Sugimoto M
Clin Med Insights Circ Respir Pulm Med. 2015; 9(Suppl 1):29-40.
PMID: 26396551
PMC: 4562607.
DOI: 10.4137/CCRPM.S23286.
Pneumocystis jirovecii--from a commensal to pathogen: clinical and diagnostic review.
Sokulska M, Kicia M, Wesolowska M, Hendrich A
Parasitol Res. 2015; 114(10):3577-85.
PMID: 26281787
PMC: 4562001.
DOI: 10.1007/s00436-015-4678-6.
SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs.
Standaert-Vitse A, Aliouat-Denis C, Martinez A, Khalife S, Pottier M, Gantois N
PLoS One. 2015; 10(6):e0130358.
PMID: 26103633
PMC: 4477875.
DOI: 10.1371/journal.pone.0130358.
Colonization of Pneumocystis jirovecii in Chronic Obstructive Pulmonary Disease (COPD) patients and the rate of Pneumocystis pneumonia in Iranian non-HIV(+) immunocompromised patients.
Sheikholeslami M, Sadraei J, Farnia P, Forozandeh M, Kochak H, Tabarsi P
Iran J Microbiol. 2015; 5(4):411-7.
PMID: 25848514
PMC: 4385170.
Infections in the immunosuppressed host.
George M, Masur H, Norris K, Palmer S, Clancy C, McDyer J
Ann Am Thorac Soc. 2014; 11 Suppl 4:S211-20.
PMID: 25148427
PMC: 4200572.
DOI: 10.1513/AnnalsATS.201401-038PL.
Pneumocystis jirovecii colonization is associated with enhanced Th1 inflammatory gene expression in lungs of humans with chronic obstructive pulmonary disease.
Fitzpatrick M, Tedrow J, Hillenbrand M, Lucht L, Richards T, Norris K
Microbiol Immunol. 2014; 58(3):202-11.
PMID: 24438206
PMC: 4106795.
DOI: 10.1111/1348-0421.12135.
Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.
Kling H, Shipley T, Guyach S, Tarantelli R, Morris A, Norris K
J Acquir Immune Defic Syndr. 2013; 65(4):381-9.
PMID: 24121760
PMC: 3957095.
DOI: 10.1097/QAI.0000000000000007.
Life-threatening infections in medically immunocompromised patients.
Al-Dorzi H, Khan R, Arabi Y
Crit Care Clin. 2013; 29(4):807-26.
PMID: 24094378
PMC: 7135357.
DOI: 10.1016/j.ccc.2013.06.002.
